BLIP
NDC 82966-303, Nicotine Polacrilex, lozenge, from Blip Products, Inc..
- Product NDC
- 82966-303
- Status
- Listed
- Labeler
- Blip Products, Inc.
- Dosage form
- LOZENGE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA203690
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82966-303 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NICOTINE4 mg/1
Pharmacologic classes
Cholinergic Nicotinic Agonist [EPC]; Nicotine [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82966-303-00 | 82966030300 | 1 CONTAINER in 1 CARTON (82966-303-00) / 27 LOZENGE in 1 CONTAINER (82966-303-27) |
| 82966-303-10 | 82966030310 | 4 CONTAINER in 1 CARTON (82966-303-10) / 27 LOZENGE in 1 CONTAINER (82966-303-27) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 82966-303 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82966-303 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82966-303. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.